Author: OurCrowd

[yulife in Cover Magazine] Surge in demand for wellness apps, study shows

“The findings emphasize the need for the insurance industry to move out of the adversarial model and create a win-win situation for both the insurer and the policy-holder, while simultaneously revealing the importance employees place on wellbeing,” said Rubin. “At YuLife we are proud to be propelling the industry forward in the both of these crucial aspects.” Read...

Read More

[Morphisec in Security Boulevard] Morphisec Special Offer: Full Best-in-Class Endpoint Protection At A Lower Price Than Your Current Antivirus

The sudden transition to remote workforces that COVID-19 brought about has sparked questions across the board for IT spending. Antivirus protection is not immune, as more and more companies question whether their antivirus — even the “next-gen” AV platforms — are really reducing the risk of a breach in the face of constantly evolving attacker techniques. The answer is likely no, as the cost of a successful breach has increased 25 percent year over year, to reach $8.94 million in 2019. Read...

Read More

[MigVax in NoCamels] Israel Set To Launch Human Trials For Covid-19 Vaccine After High Holidays

In late April, Israeli scientists at the Migal Galilee Research Institute formed a new company, MigVax, to further adapt a vaccine they developed for a deadly coronavirus affecting poultry for human use. The scientists had been working for four years to develop a vaccine for IBV (Infectious Bronchitis Virus) which affects the respiratory tract, gut, kidney and reproductive systems of domestic fowl. Read...

Read More

[TechSee in PR Newswire] TechSee becomes Pega® ISV Partner

TechSee, a global leader in Visual Customer Assistance powered by AI and Augmented Reality, today announced that it has joined the Pega Independent Software Vendor (ISV) Partner Program. The Pega ISV Partner Program extends clients’ Pega investments with readily available, out-of-the-box solutions to further accelerate their time to market. Read more...

Read More